Movement Disorders in Dental Practice

  • Nina M. Browner
  • Steven Frucht


Deep Brain Stimulation Movement Disorder West Nile Virus Multiple System Atrophy Dementia With Lewy Body 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aarsland, D., Zaccai, J., & Brayne, C. (2005). A systematic review of prevalence studies of dementia in Parkinson’s disease. Movement Disorders, 20, 1255–1263.PubMedCrossRefGoogle Scholar
  2. Ackermans, L., Temel, Y., Cath, D., van der Linden, C., Bruggerman, R., Kleijer, M., Nederveen, P., Schruers, K., Colle, H., Tijssen, M.A., Visser-Vandewalle, V., & Dutch Flemish Tourette Surgery Study Group. (2006). Deep brain stimulation in Tourette’s syndrome: two targets? Movement Disorders, 21, 709–713.Google Scholar
  3. Alexander, R.E., & Gage, T.W. (2000). Parkinson’s disease: an update for dentists. General Dentistry, 48, 572–580.PubMedGoogle Scholar
  4. Blanchet, P.J., Allard, P., Gregoire, L., Tardif, F., & Bernard, P.J. (1996). Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients. Canadian Journal of Neurological Science, 23, 189–193.Google Scholar
  5. Blanchet, P.J., Rompre, P.H., Lavingne, G.J., & Lamarche, C. (2005). Oral dyskinesia: a clinical overview. The International Journal of Prosthodontics, 18, 10–19.PubMedGoogle Scholar
  6. Bonifati, V., Rizzi, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., & Dekker, M.C. (2003). Mutation in DJ-1 gene associated with autosomal recessive early – onset parkinsonism. Science, 299, 256–259.PubMedCrossRefGoogle Scholar
  7. Bower, J.H., Maraganore, D.M., McDonnell, S.K., & Rocca, W.A. (1997). Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota 1976–1990. Neurology, 49, 1284–1288.PubMedGoogle Scholar
  8. Bower, J.H., Maraganore, D.M., & McDonnell, S.K. (1999). Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology, 52, 1214–1220.PubMedGoogle Scholar
  9. Bradford, H., Britto, L.R., Leal, G., & Katz, J. (2004). Endodontic treatment of a patient with Huntington’s disease. Journal of Endodontics, 30, 366–369.PubMedCrossRefGoogle Scholar
  10. Bressman, S.B. (2000). Dystonia update. Clinical Neuropharmacology, 23, 239–251.PubMedCrossRefGoogle Scholar
  11. Bressman, S.B., Sabatti, C., Raymond, D., de Leon D, Klein, C., Kramer, P.L., Brin, M.F., Fahn, S., Breakefield, X., Oselius, L.J., & Risch, N.J. (2000). The DYT1 phenotype and guidelines for diagnostic testing. Neurology, 54, 1746–1752.PubMedGoogle Scholar
  12. Chakos, M.H., Alvir, J.M.J., Woerner, M.G., Koreen, A., Geisler, S., Mayerhoff, D., Sobel, S., Kane, J.M., Borenstein. M., & Lieberman, J.A. (1996). Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Archives of General Psychiatry, 53, 313–319.PubMedGoogle Scholar
  13. Clifford, T., & Finnerty, J. (1995). The dental awareness and needs of Parkinson’s disease population. Gerontology, 12, 99–103.Google Scholar
  14. Collins, R. (1990). Special considerations for the dental patient with Parkinson’s disease. Texas Dentistry Journal, 107, 31–33.Google Scholar
  15. Comings, D.E., Himes, J.A., & Comings, B.G. (1990). An epidemiologic study of Tourette’s syndrome in a single school district. Journal of Clinical Psychiatry, 51, 463–469.PubMedGoogle Scholar
  16. Deuschl, G., & Elble, R.J. (2000). The pathophysiology of essential tremor. Neurology, 54 (suppl. 4), S14–S20.PubMedGoogle Scholar
  17. Dujardin, K., Defbvre, L., & Grunberg, C. (2001). Memory and executive function in sporadic and familial Parkinson’s disease. Brain, 123, 115–1160.Google Scholar
  18. Fahn, S., Bressman, S.B., & Marsden, C.D. (1998). Classification of dystonia. Advances in Neurology, 78, 1–10.PubMedGoogle Scholar
  19. Feeney, A.W. (1985). Dental treatment considerations for patients with Huntington’s chorea: a literature review and case report. Journal of Connecticut State Dental Association, 59, 118–123.Google Scholar
  20. Findley, L.J. (2000). Epidemiology and genetics of essential tremor. Neurology, 54 (suppl 4),S8–S13.PubMedGoogle Scholar
  21. Friedlander, A.H., & Cummings, J.L. (1992). Dental treatment of patients with Gilles de la Tourette’s syndrome. Oral Surgery, Oral Medicine and Oral Pathology, 73, 299–303.CrossRefGoogle Scholar
  22. Frucht, S., Fahn, S., Ford, B., & Gelb, M. (1999). A geste antagoniste device to treat jaw – closing dystonia. Movement Disorders, 14, 883–886.PubMedCrossRefGoogle Scholar
  23. Fukayo, S., Nonaka, K., Shimizu, T., & Yano, E. (2003). Oral health of patient with Parkinson’s disease: factors related to their better dental status. Tohoku Journal of Experimental Medicine, 201, 171–179.PubMedCrossRefGoogle Scholar
  24. Geene, P., Kahn, U.J., & Fahn, S. (1995). Spread of symptoms in idiopathic torsion dystonia. Movement Disorders, 10, 143–152.CrossRefGoogle Scholar
  25. Golbe, L.I., Davis, P.H., Schoenberg, B.S., & Duvoisin, R.C. (1988). Prevalence and natural history of progressive supranuclear palsy. Neurology, 38, 1031–1034.PubMedGoogle Scholar
  26. Greene, P., Shale, H., & Fahn, S. (1988). Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Advances in Neurology, 50, 547–556.PubMedGoogle Scholar
  27. Jankovic, J. (2004). Dystonia: medical therapy and botulinum toxin. Advances of Neurology, 94, 275–286.Google Scholar
  28. Jeste, D.V., & Wyatt, R.J. (1982). Therapeutic strategies against tardive dyskinesia; two decades of experience. Archives of Psychiatry, 39, 803–816.Google Scholar
  29. Jost, W.H., & Kohl, A. (2001). Botulinum toxin: evidence-based medicine criteria in rare indications. Journal of Neurology, 248 (suppl 1), 39–44.PubMedCrossRefGoogle Scholar
  30. Kane, J.M., & Smith, J.M. (1982). Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Archives of General Psychiatry, 39, 473–481.PubMedGoogle Scholar
  31. Kane, J.M., Woerner, M., Borenstein, M., Wegner, J., & Lieberman, J. (1986). Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacology Bulletin, 22, 254–258.PubMedGoogle Scholar
  32. Kelleher, M.G.D., Scott, B.J.J., & Djemal, S. (1998). Case report: Complications of rehabilitation using osseointegrated implants – tardive dyskinesia. European Journal of Prosthodontics and Restorative Dentistry, 6, 133–136.Google Scholar
  33. Kitada, T., Asakawa, S., Hattori, N., &Yamamura, Y. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605–608.PubMedCrossRefGoogle Scholar
  34. Kokmen, E., Ozekmekci, F.S, Beard, C.M,, O’Brien, P.C, & Kurland, L.T. (1994). Incidence and prevalence of Huntington’s disease in Olmsted County, Minnesota (1950 through 1989). Archives of Neurology, 51, 696–698.PubMedGoogle Scholar
  35. Koller, W.C. (1983). Edentulous orodyskinesia. Annals of Neurology, 13, 97–99.PubMedCrossRefGoogle Scholar
  36. Koller, W.C., Hristova, A., & Brin, M. (2000a). Pharmacologic treatment of essential tremor. Neurology, 54 (suppl 4), S30–S38.Google Scholar
  37. Koller, W.C., Pahwa, R., Lyons, K.E., & Wilkinson, S.B. (2000b). Deep brain stimulation of the Vim nucleus of the thalamus for the treatment of tremor. Neurology, 55 (suppl 6), S29–S33.Google Scholar
  38. Kramer, P.L., Mineta, M., Klein, C., Schilling K, de Leon, D., Farlow, M.R., Breakefield, X.O., Bressman, S.B., Dobyns, W.B., Ozelius, L.J, & Brashear. A. (1999). Rapid onset dystonia-parkinsonism: linkage to chromosome 19q13. Annals of Neurology, 46, 176–182.PubMedCrossRefGoogle Scholar
  39. Kurlan, R. (2003). Tourette’s syndrome: are stimulants safe? Current Neurology and Neuroscience Reports, 3, 285–288.PubMedCrossRefGoogle Scholar
  40. Kwak, C.H., Hanna, P.A., Jankovic, J. (2000). Botulinum toxin in the treatment of tics. Archives of Neurology, 57, 1190–1193.PubMedCrossRefGoogle Scholar
  41. Langston, J.W., Forno, L.S., Tetrud, J., Reeves, A.G., Kaplan, J.A., & Karluk, D. (1999). Evidence of active nerve cell degeneration in the substantia nigra of human years after 1-methyl-4-phenyl–1,2,3,6–tetrahydropyridine exposure. Annals of Neurology, 46, 598–605.PubMedCrossRefGoogle Scholar
  42. Lauciello, F., & Appelbaum, M. (1977). Prosthodontic implication of tardive dyskinesia. New York State Dentistry Journal, 43, 214–217.Google Scholar
  43. Leksell,E., & Edvardson, S. (2005). A case of Tourette syndrome presenting with oral self-injurious behavior. International Journal of Pediatric Dentistry, 15, 370–374.CrossRefGoogle Scholar
  44. Litvan, I., MacIntyre, A., Goetz, C.G., Wenning, G.K., Jellinger, K., Verny, M., Bartko, J.J., Jankovic, J., McKee, A., Brandel, J.P., Chaudhuri, K.R., Lai, E.C., D’Olhaberriaque, L., Pearce, R.K., & Agid, Y. (1998). Accuracy of the clinical diagnoses of Lewy body disease, Parkinson’s disease and dementia with Lewy bodies: a clinicopathologic study. Archives of Neurology, 55, 969–978.PubMedCrossRefGoogle Scholar
  45. Litvan, I., Grimes, D.A., Lang, A.E., Jankovic, J., McKee, A., Verny, M., Jellinger, K., Chaundhuri, K.R., & Pearce, R.K. (1999). Clinical feature differentiating patient with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. Journal of Neurology, 246 ( suppl 2), II1–II5.PubMedCrossRefGoogle Scholar
  46. Lo, S.E., Gelb, M., & Frucht, S.J. (2007). Geste antogoniste in idiopathic lower cranial dystonia. Movement Disorders, 22, 1012–1017.Google Scholar
  47. Lozano, A.M., & Abosch, A. (2004). Pallidal stimulation for dystonia. Advances in Neurology, 94, 301–308.PubMedGoogle Scholar
  48. McKeith, I.G., Dickson, D.W., Lowe, J., Emre, M., O’Brien, J.T., Feldman, H., Cummings, J., Duda, J.E., Lippa, C., & Perry, E.K. (2005). Diagnosis and management of dementia with Lewy bodies: third report on the DLB consortium. Neurology, 65, 1863–1872.PubMedCrossRefGoogle Scholar
  49. Mink, J.W. (2001). Basal ganglia dysfunction in Tourette’s syndrome: a new hypothesis. Pediatrics Neurology, 25, 190–198.CrossRefGoogle Scholar
  50. Nakayama, Y., Washio, M., & Mori, M. (2004). Oral health conditions in patients with Parkinson’s disease. Journal of Epidemiology, 14, 143–150.PubMedCrossRefGoogle Scholar
  51. Nutt, J.G., Muenter, M.D., Aronson, A., Kurland, L.T., & Melton, L.J. 3rd. (1988). Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Movement Disorders, 3,188–194.PubMedCrossRefGoogle Scholar
  52. Olanow, C.W., Goetz, C.G., Kordower, J.H., Stoessl, A.J., Sosi, V., Brin, M.F., Shannon, K.M., Nauert, G.M., Perl, D.P., Godbold, J., & Freeman, T.B. (2003). A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Annals of Neurology, 54,403–414.PubMedCrossRefGoogle Scholar
  53. Paisan-Ruiz, C., Lang, A.E., Kawarai, T., & Sato, C. (2005). LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology, 65, 696–700.PubMedCrossRefGoogle Scholar
  54. Polymeropoulos, M.H., Lavedan, C., & Leroy, E. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science, 276, 2045–2047.PubMedCrossRefGoogle Scholar
  55. Pradhan, S., Pander, N., Shashank, S., Gupta, R.K., & Mathur, A. (1999). Parkinsonism due to predominant involvement of substantia nigra in Japanese Encephalitis. Neurology, 53,1781–1786.PubMedGoogle Scholar
  56. Rajput, A.H. (1994). Clinical features and natural history of Parkinson’s disease (Special consideration of aging). In: D.B. Calne (Eds.), Neurodegenerative diseases (pp. 555–571). Philadelphia: WB Saunders.Google Scholar
  57. Riley, D., & Lang, A.E. (1989). Pain in Gilles de la Tourette’s syndrome and related tic disorders. Canadian Journal of Neurological Science, 16, 439–441.Google Scholar
  58. Rodriquez-Oroz, M.C., Obeso, J.A., Lang, A.E., Houeto, J.L. , Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M.I., Quinn, N.P., Speelman, J.D., Guridi, J., Zamarbide, I., Gironell, A., Molet, J., Pascual-Sedno, B., Pidoux, B., Bonnet, A.M., Ajid, Y., Xie, J., Benabid, A.L., Lozano, A.M., Saint-Cyr, J., Romito, L., Contarino, M.F., Scerrati, M., Fraix, V., & Van Blercom, N. (2005). Bilateral deep brain stimulation in Parkinson’s disease: a multicentral study with 4 years follow – up. Brain, 128, 2240–2249.CrossRefGoogle Scholar
  59. Saito, Y., Matsuoka, Y., Takahashi, A., & Ohno, Y. (1994). Survival of patients with multiple system atrophy. Internal Medicine, 33, 321–325.PubMedGoogle Scholar
  60. Sankhla, C., Lai, E.C., & Jankovic, J. (1998). Peripherally induced oromandibular dystonia. Journal of Neurology, Neurosurgery and Psychiatry, 65, 722–728.CrossRefGoogle Scholar
  61. Santacruz, P., Uttl, B., Livan, I., & Grafman, J. (1998). Progressive supranuclear palsy: A survery of the disease course. Neurology, 50, 1637–1647.PubMedGoogle Scholar
  62. Schoenberg, B.S., Anderson, D.W., & Haerer, A.F. (1985). Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology, 35, 841–845.PubMedGoogle Scholar
  63. Schrag, A., Ben-Shlomo, Y., & Quinn, N.P. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross – sectional study. Lancet, 354, 1771–1775.PubMedCrossRefGoogle Scholar
  64. Schrag, A., Bhatia, K.P, Quinn, N.P, & Marsden, C.D. (1999). Atypical and typical cranial dystonia following dental procedures. Movement Disorders, 14, 492–496.PubMedCrossRefGoogle Scholar
  65. Segawa, M., Hosaka, A., Miyagawa, F., Nomura, Y., & Imai H. (1976). Hereditary progressive dystonia with marked diurnal fluctuation. Advances in Neurology, 14, 215–233.Google Scholar
  66. Sejvar, J.J., Haddad, M.B., Tierney, B.C., Campbell, G.L., Marfin, A.A., Van Gerpen, J.A., Fleischauer, A., Leiss, A.A., Stokic, D.S., & Petersen, L.R . (2003). Neurologic manifestations and outcome of West Nile Virus infection. Journal of American Medical Association, 290, 511–515.CrossRefGoogle Scholar
  67. Shahed, J., Poysky, J., Kenney, C., Simpson, R., & Jankovic, J. (2007). GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbilities. Neurology, 68, 159–160.PubMedCrossRefGoogle Scholar
  68. Singer, C. (1997). Tourette syndrome. Coprolalia and other coprophenomena. Neurological Clinics, 15, 299–308.CrossRefGoogle Scholar
  69. Sutcher, H., Soderstrom, J., Perry, R., & Das, A. (1998). Tardive dyskinesia: dental prosthetic therapy. Panminerva medica, 40, 154–156.PubMedGoogle Scholar
  70. Sutcher, H.D., Underwood, R.B., Beatty, R.A., & Sugar O. (1971). Orofacial dyskinesia – a dental dimension. Journal of American Medical Association, 216, 1459–1463.CrossRefGoogle Scholar
  71. Tanner, C.M. (1992). Occupational and environmental causes of parkinsonism. Occupational Medicine, 7, 503–513.PubMedGoogle Scholar
  72. Uc, E.Y., Rizzo, M., Anderson, S.W., & Qian, S. (2005). Visual dysfunction in Parkinson disease without dementia. Neurology, 65, 1907–1913.PubMedCrossRefGoogle Scholar
  73. Volkmann, J., Allert, N., Vodes, J., Weiss, P.H., Freund, H.J., & Sturm, V. (2001). Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology, 57, 1354–1358.Google Scholar
  74. Waddy, H.M., Fletcher, N.A,, Harding, A.E., Marsden, C.D. (1991). A genetic study of idiopathic dystonias. Annals of Neurology, 29, 320–324.PubMedCrossRefGoogle Scholar
  75. Woody, R.C., & Eisenhauer, G. (1986). Tooth extraction as a form of self- mutilation in Tourette’s disorder. South Medical Journal, 79, 1466.CrossRefGoogle Scholar
  76. Yoshikawa, F., Takagi, T., Fukayama, H., Miwa, Z., & Umino, M. (2002). Intravenous sedation and general anesthesia for a patient with Gilles de la Tourette’s syndrome undergoing dental treatment. Acta Anasthesiologica Scandinavia, 46, 1279–1280.CrossRefGoogle Scholar
  77. Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007). Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. New England Journal of Medicine, 356, 39–46.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Nina M. Browner
    • 1
  • Steven Frucht
  1. 1.Professor of Behavioral and Community Health Sciences Graduate School of Public HealthUniversity of PittsburghNI3 New York

Personalised recommendations